White Blood Cell Study: Cytapheresis of Volunteer Donors - No Study Results Posted - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

White Blood Cell Study: Cytapheresis of Volunteer Donors

This study is currently recruiting participants.

Study NCT00104325 Information provided by National Institutes of Health Clinical Center (CC)

First Received: February 24, 2005 Last Updated: July 21, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	December 2016
Estimated Primary Completion Date:	December 2016 (Final data collection date for primary outcome measure)

Publications:

Almanzar G, Olkhanud PB, Bodogai M, Dell'agnola C, Baatar D, Hewitt SM, Ghimenton C, Tummala MK, Weeraratna AT, Hoek KS, Kouprina N, Larionov V, Biragyn A. Sperm-derived SPANX-B is a clinically relevant tumor antigen that is expressed in human tumors and readily recognized by human CD4+ and CD8+ T cells. Clin Cancer Res. 2009 Mar 15;15(6):1954-63. Epub 2009 Mar 10.

Nguyen DH, Taub D. CXCR4 function requires membrane cholesterol: implications for HIV infection. J Immunol. 2002 Apr 15;168(8):4121-6.

Nguyen DH, Taub DD. Membrane incorporation of 22-hydroxycholesterol inhibits chemokine receptor activity. Exp Cell Res. 2003 May 1;285(2):268-77.

Back to top of Main Content